-
Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US
Information about social determinants of health associated with racial and ethnic health disparities and inequities in MS, NMOSD, and MOGAD. The paucity of research addressing…
-
The impact of socioeconomic status on mental health and health-seeking behavior across race and ethnicity in a large multiple sclerosis cohort
In a survey of over 2,000 people with MS, higher socioeconomic status was associated with a lower burden of psychiatric symptoms and with a higher…
-
Mapping two decades of multiple sclerosis rehabilitation trials: A systematic scoping review and call to action to advance the study of race and ethnicity in rehabilitation research
A meta-analysis of MS rehabilitation trials found that fewer than 10% of participants were people of Black, Latinx/Hispanic, Asian, Indigenous, or Arab ethnicity, indicating a…
-
The Black MS Experience
Information and videos about the impact of MS on the Black community, and the importance of health equity and self-advocacy to optimize health outcomes for…
-
ShareTools
ShareTools is a resource for health profession educators to integrate humanities based, anti-racism education. Click here to access this resource.
-
Health Equity in Multiple Sclerosis Training
As part of its professional education offerings, the National MS Society has a vetted collection of programs that highlight health equity strategy implementation, further describe…
-
Racial disparities in Medicaid home and community-based service utilization and expenditures among persons with multiple sclerosis
The authors of this article looked at disparities in utilization of home and community based services (HCBS) among 7,550 White and Black individuals covered by…
-
Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of Multiple Sclerosis DMTs
This research article evaluates ethnic and racial representation in DMT clinical trials and how it has evolved over time. Non-White PwMS are significantly underreported and…
-
Enhancing the Diversity of Clinical Trial Populations – Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry
Over the past few decades, FDA has promoted enrollment practices that would lead to clinical trials that better reflect the population most likely to use…
Spot our logo in the upper right for resources that were produced internally.
